
βΉ1,896 Original price was: βΉ1,896.βΉ1,400Current price is: βΉ1,400.
Order Online
Need a prescription?
Consult our doctor and get one online.
Uses & Benefits
Uses & Benefits
Key Benefits
EMTAF PrEP contains two nucleoside reverse transcriptase inhibitors (NRTIs)
Emtricitabine and Tenofovir Alafenamide prevent HIV from replicating in the body by inhibiting
reverse transcriptase, a key enzyme in the virus's replication process.
This stops HIV from establishing a permanent infection in high-risk individuals.
Caution is advised when consuming alcohol with EMTAF Tablet. Please consult your doctor for guidance.
EMTAF Tablet is unsafe to use during pregnancy due to potential harm to the developing baby. It may only be prescribed in life-threatening situations where benefits outweigh the risks. Please consult your doctor.
There is insufficient information on the use of EMTAF Tablet while breastfeeding. Please consult your doctor before use.
It is uncertain whether EMTAF Tablet affects your ability to drive. Avoid driving if you experience drowsiness, dizziness, or reduced alertness.
Limited data is available on the safety of EMTAF Tablet in patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.
EMTAF Tablet should be used with caution in patients with liver disease. Dose adjustments may be required based on the severity of the condition. Please consult your doctor.
βΉ1,943 Original price was: βΉ1,943.βΉ1,000Current price is: βΉ1,000.
βΉ1,540 Original price was: βΉ1,540.βΉ1,000Current price is: βΉ1,000.
βΉ1,540 Original price was: βΉ1,540.βΉ1,000Current price is: βΉ1,000.
βΉ2,000 Original price was: βΉ2,000.βΉ1,200Current price is: βΉ1,200.